EZH2 and colorectal carcinoma: (111) found that the combination of lncRNA CRNDE and EZH2, a key component of PRC2, inhibited the expression of two downstream target genes dual-specific phosphatase 5 (DUSP5) and CDKN1A, which play important roles in CRC proliferation and metastasis.